A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia

University Hospital, Montpellier1 site in 1 country60 target enrollmentApril 1, 2014

ConditionsSchizophrenia

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Schizophrenia
Sponsor: University Hospital, Montpellier
Enrollment: 60
Locations: 1
Primary Endpoint: Scale for the Assessment of Negative Symptoms
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to evaluate the therapeutic efficacy of a neuromodulation technique, tDCS (transcranial direct current stimulation) used as a complementary treatment on negative symptoms. 60 patients will be randomized into two groups (active tDCS vs sham tDCS) and will be assessed after the intervention, 1 and 3 months after.Secondary outcomes shall include neuropsychological assessment, general symptomatology, extrapyramidal symptoms and social functioning.

Registry

clinicaltrials.gov

Start Date

April 1, 2014

End Date

October 26, 2018

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel